HR 2376
115th Congress
House
Health
Consumer affairs
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Fraud offenses and financial crimes
Manufacturing
Drug Diversion and Counterfeit Crackdown Act of 2017
Introduced: May 4, 2017
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 5, 2017
Referred to the Subcommittee on Health.
May 4, 2017
Referred to the House Committee on Energy and Commerce.
May 4, 2017
Introduced in House
Plain-English summary
Drug Diversion and Counterfeit Crackdown Act of 2017
This bill makes it illegal except in cases of a drug shortage to import into the United States prescription drugs manufactured outside the United States and intended by the manufacturer or labeled to be marketed outside the United States.
The bill establishes a penalty for knowingly dispensing or selling a counterfeit drug.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2
Cosponsors
1